Public recall detail

Vyvanse Capsule (2019-08-08)

medium
Recall Safety notice
Quick summary

Quick summary: Vyvanse Capsule (2019-08-08) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Vyvanse Capsule (2019-08-08) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionVyvanse 20 mg Capsule DIN, NPN, DIN-HIM DIN 02347156 Dosage form Capsule Strength Lisdexamfetamine dimesylate 20 mg Lot or serial number AG4982B Companies Recalling Firm Shire Pharma Canada ULC 22 Adelaide St West, Suite 3800 Toronto M5H 4E3 Ontario CANADA Marketing Authorization Holder Shire Pharma Canada ULC 22 Adelaide St West, Suite 3800 Toronto M5H 4E3 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...